Skip to main content
TipRanks
Go Ultimate75% OFF

Glenmark Life Sciences Limited (ALIVUS) Ratios

6 Followers

Glenmark Life Sciences Limited Ratios

IN:ALIVUS's free cash flow for Q2 2025 was ₹1.48B. For the 2025 fiscal year, IN:ALIVUS's free cash flow was decreased by ₹-1.13B and operating cash flow was ₹2.61B. See a summary of the company’s cash flow.

Financial ratios
RatiosMar 25Mar 24Mar 22Mar 21Mar 20
Liquidity Ratios
Current Ratio5.214.974.601.150.67
Quick Ratio3.853.533.250.730.38
Cash Ratio0.000.151.330.090.00
Solvency Ratio0.980.921.100.310.22
Operating Cash Flow Ratio1.110.881.560.320.01
Short-Term Operating Cash Flow Coverage0.000.00-530.710.42492.95
Net Current Asset Value₹ 19.99B₹ 17.41B₹ 13.48B₹ 1.55B₹ -4.57B
Leverage Ratios
Debt-to-Assets Ratio0.010.020.000.470.00
Debt-to-Equity Ratio0.020.020.001.240.00
Debt-to-Capital Ratio0.020.020.000.550.00
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.201.211.202.6516.74
Debt Service Coverage Ratio120.11227.2818.060.46218.85
Interest Coverage Ratio134.39258.4120.706.42389.76
Debt to Market Cap0.000.00-0.000.120.00
Interest Debt Per Share5.064.822.6294.650.05
Net Debt to EBITDA0.07-0.02-0.811.38-0.01
Profitability Margins
Gross Profit Margin44.57%32.20%50.88%51.97%55.41%
EBIT Margin29.65%27.68%27.92%29.63%28.79%
EBITDA Margin32.61%30.24%29.71%31.40%17.66%
Operating Profit Margin28.29%26.30%27.27%29.80%16.78%
Pretax Profit Margin29.44%27.58%26.61%24.98%28.74%
Net Profit Margin22.12%20.47%19.72%18.65%20.83%
Continuous Operations Profit Margin22.12%20.47%19.72%18.65%20.83%
Net Income Per EBT75.13%74.24%74.12%74.65%72.47%
EBT Per EBIT104.07%104.86%97.58%83.84%171.26%
Return on Assets (ROA)14.17%14.24%16.95%17.60%19.84%
Return on Equity (ROE)16.94%17.24%20.38%46.71%332.11%
Return on Capital Employed (ROCE)20.78%21.21%27.74%72.42%248.26%
Return on Invested Capital (ROIC)15.57%15.71%20.56%24.65%179.88%
Return on Tangible Assets14.28%14.32%17.02%17.67%19.92%
Earnings Yield4.72%3.83%7.77%4.36%3.19%
Efficiency Ratios
Receivables Turnover2.382.353.152.763.04
Payables Turnover3.804.123.564.073.34
Inventory Turnover2.042.392.021.761.56
Fixed Asset Turnover1.982.273.143.262.65
Asset Turnover0.640.700.860.940.95
Working Capital Turnover Ratio1.270.002.73124.63-6.23
Cash Conversion Cycle235.94219.71193.92249.33244.30
Days of Sales Outstanding153.47155.36115.78132.10119.94
Days of Inventory Outstanding178.56152.97180.68206.96233.55
Days of Payables Outstanding96.0988.63102.5489.73109.19
Operating Cycle332.03308.34296.46339.05353.49
Cash Flow Ratios
Operating Cash Flow Per Share46.1333.5850.8536.000.84
Free Cash Flow Per Share21.1120.0139.6029.690.08
Dividend Paid and CapEx Coverage Ratio1.542.482.295.711.11
Capital Expenditure Coverage Ratio1.842.484.525.711.11
Operating Cash Flow Coverage Ratio9.977.27207.210.42492.95
Operating Cash Flow to Sales Ratio0.220.170.280.210.01
Free Cash Flow Yield2.17%1.94%8.63%3.97%0.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio21.1826.0912.8822.9531.34
Price-to-Sales (P/S) Ratio4.695.342.544.286.53
Price-to-Book (P/B) Ratio3.594.502.6210.72104.07
Price-to-Free Cash Flow (P/FCF) Ratio46.1551.6611.5925.218930.05
Price-to-Operating Cash Flow Ratio21.1230.799.0220.79885.93
Price-to-Earnings Growth (PEG) Ratio1.320.001.391.87-0.00
Enterprise Value Multiple14.4417.647.7415.0136.95
Enterprise Value120.12B126.53B48.83B88.86B91.69B
EV to EBITDA14.4417.647.7415.0136.95
EV to Sales4.715.332.304.716.53
EV to Free Cash Flow46.3651.6010.4927.768928.06
EV to Operating Cash Flow21.2230.768.1722.90885.73
Tangible Book Value Per Share269.04228.29173.9169.096.67
Shareholders’ Equity Per Share271.48229.92174.8069.827.19
Tax and Other Ratios
Effective Tax Rate0.250.260.260.250.28
Revenue Per Share207.91193.57180.66174.87114.67
Net Income Per Share45.9939.6335.6332.6123.89
Tax Burden0.750.740.740.750.72
Interest Burden0.991.000.950.841.00
Research & Development to Revenue0.000.000.030.000.00
SG&A to Revenue0.160.020.000.000.01
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality1.000.631.060.820.05

Currency in INR